IDEXX Laboratories Inc
NASDAQ:IDXX
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.2B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.2B EUR |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
130B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.6B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
33.1B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.1B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
IDEXX Laboratories Inc
Glance View
IDEXX Laboratories Inc. stands as a pillar of innovation in the realm of veterinary diagnostics, transforming the landscape of animal healthcare. Founded in 1983, the company has strategically positioned itself at the intersection of science and care, delivering a broad range of products and services that cater primarily to veterinarians. By offering state-of-the-art diagnostic tests and in-house laboratory equipment, IDEXX empowers veterinarians to make precise and timely decisions. These tools not only enhance animal health but also streamline veterinary practices, allowing them to offer clients rapid, reliable results. By investing heavily in research and development, IDEXX continuously enhances its product portfolio, maintaining a competitive edge in a market that demands constant innovation. In addition to its core veterinary diagnostic services, IDEXX extends its expertise into water testing and livestock and poultry diagnostics, though these segments are smaller. The company crafts its revenue model on providing recurring, subscription-based services for its diagnostic machines, which require regular updating with new test kits and consumables. This model ensures a durable revenue stream, fostering long-term relationships with veterinary clinics worldwide. As digital transformation sweeps through every industry, IDEXX has also embraced the digital age, crafting sophisticated software that aids veterinarians in managing their practices more efficiently, thus augmenting its revenue through IT solutions. This diversified yet synergistic approach has allowed IDEXX to remain resilient and grow steadily, delivering consistent value to both its clients and shareholders.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for IDEXX Laboratories Inc is 24.6%, which is above its 3-year median of 23%.
Over the last 3 years, IDEXX Laboratories Inc’s Net Margin has increased from 20.2% to 24.6%. During this period, it reached a low of 20.2% on Dec 31, 2022 and a high of 24.7% on Aug 30, 2025.